Skip to main content
. 2015 Jul 1;18(7):786–792. doi: 10.1089/jmf.2014.0053

FIG. 2.

FIG. 2.

Effects of SLCP formulations on LPS-induced production of pro-inflammatory cytokine, IL-6, in RAW 264.7 cells. The SLCP formulations were able to suppress IL-6 levels in a concentration-dependent manner. Data are expressed as mean values±SD. aP<.001 and cP<.05 indicate a significant difference as compared with the LPS-treated group. AU, arbitrary units; IL-6, interleukin-6.